Publications & Presentations

We would like to thank our patients for their participation in research studies. Your contribution has made a lasting impact on the field and will advance the care of future patients!

Selected Publications and Presentations

• Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
• A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study
• Use of the BASDAI in Psoriatic Arthritis Patients With and Without Axial Disease
• The impact of dietary interventions in psoriatic arthritis
• H. Ralph Schumacher
• Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial
• Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
• Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
• Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System
• Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials
• Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study

PubMed Feed

• Agreement of administrative pharmacy dispensing with self-reported use of oral prednisone in US Veterans with rheumatoid arthritis.
  Arthritis care & research. 2025 Jun 2; Authors: Wallace BI, England BR, Baker JF, George MD, Sauer BC, Rojas J, Roul P, Wysham KD, Brubeck H, Smith I, Caplan L, Monach PA, Kerr GS, Kunkel G, Braaten T, Mikuls TR, Cannon GW

• A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials.
  Rheumatology and therapy. 2025 Jun;12(3):595-596 Epub 2025 Mar 17; Authors: Wright GC, Mysler E, Yndestad A, Kinch CD, Ogdie A

• Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis.
  Rheumatology (Oxford, England). 2025 Jun 1;64(6):3921-3928; Authors: Riley TR, Wheeler AM, Cannon GW, Sauer B, Wysham KD, England BR, Wipfler K, Michaud K, March M, Damrauer SM, Verma A, George MD, Mikuls TR, Baker JF

• Prevalence of Frailty and Associated Factors in a US-Wide Cohort of Rheumatic Diseases.
  ACR open rheumatology. 2025 Jun;7(6):e70046; Authors: Wysham KD, Chang CLA, Singh N, Andrews JS, Wipfler K, Lieber SB, Sattui SE, Stovall R, Baker JF, Katz PP, Michaud K

• Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review.
  Best practice & research. Clinical rheumatology. 2025 May 14;:102072; Authors: Kellner DA, Morris NT, Lee SM, Baker JF, Chu P, Ranganath VK, Kaeley GS, Yang HH

• Implementing Negative Control Outcomes to Assess Comparability of Treatments for Psoriasis and Psoriatic Arthritis.
  Pharmacoepidemiology and drug safety. 2025 May;34(5):e70156; Authors: Horner ME, Ogdie A, Orroth KK, Kent ST, Tran KV, Deignan C, Cordey M, Brookhart MA

• Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines.
  Open forum infectious diseases. 2025 May;12(5):ofaf102 Epub 2025 Apr 29; Authors: Weinstein EJ, Carbonari DM, Newcomb CW, Torgersen J, Smith SM, Brecker KL, Liu XS, Kostman JR, Trooskin S, Hubbard RA, Baker JF, Zemel BS, Leonard MB, Lo Re V 3rd

• Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study.
  Seminars in arthritis and rheumatism. 2025 Apr 21;73:152735; Authors: Frideres H, Wichman CS, Dong J, Roul P, Yang Y, Baker JF, George MD, Johnson TM, Rojas J, Sauer BC, Cannon GW, Matson SM, Curtis JR, Mikuls TR, England BR

• Metabolic Consequences of Rheumatoid Arthritis.
  Arthritis care & research. 2025 Apr 2; Authors: Barry S, Sheng E, Baker JF

• Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials.
  ACR open rheumatology. 2025 Apr;7(4):e70001; Authors: Merkel PA, George MD, Yue H, Popov T, Kronbichler A, Little MA, Jayne DRW